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Objectives: To analyze the impact of promotional strategies aimed at the
consumption of medicines within the practices of both health professionals and
consumers.
Methodology: Analytical interpretation.
Results: Propaganda in the mass media is the primary advertising strategy for
medications. This is based on the biomedical model and business interests. In
the article the author selects four medical problems to analyze this strategy:
anorexia, attention deficit disorder, depression and andropause. With anorexia,
there remain incentives based on the promotion of values associated with
thinness and the possession of a healthy, beautiful and socially achievable body
through the use of amphetamines that inhibit appetite. With regard to combating
attention deficit and hyperactivity disorders, the author identifies in health
professionals the use of two strategies: One is, to publicize these disorders as
uncontrolled epidemics and exacerbate the severity of their symptoms; the other
is, to characterize these disorders through a superficial diagnosis, combined with
the study of their treatment and etiology with little scientific basis. These
practices depend on imprecise data to promote in consumers the irrational use of
medicines.
Referring to the andropause, Barros proposed that pharmaceutical companies
are using marketing to magnify low sexual performance even at a young age,
encouraging early detection through self-administered questionnaires, and
spreading distorted information about treatment with synthetic hormone
replacement. Finally, referring to depression, the author warns about the financial
benefits that companies could reach thanks to the application of two promotional
strategies for the encouragement of the use of antidepressants: one is the
construction of an exacerbated pattern of behaviors and emotions that magnifies
the identification of depressed patients, and the other is the promotion of a table
that shows positive reactions in the mood of the users through the use of drugs.
Conclusions: The use of marketing intensifies the irrational and inappropriate
consumption of drugs, generating huge profits for pharmaceutical companies.
For the author, these tactics have artificially expanded the definition of disease in
order to obtain greater number of superficially diagnosed patients. The promotion
and marketing of medicines is trapped in the logic of the market.

